Ceribell (CBLL) Share-based Compensation Growth (1y) (2024 - 2026)
Ceribell (CBLL) Share-based Compensation Growth (1y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 18.31% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -78.13% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 16.00% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 12.53% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -13.91% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 60.71% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 5.29% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 7.56% |
| 10 | Ceribell | 916.57 Mn | 787.31 Mn | 25.94 Mn | 89.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 89.39% |
| Mar 31, 2026 | 58.56% |
| Dec 31, 2025 | -27.50% |
| Sep 30, 2025 | 143.39% |
| Jun 30, 2025 | 194.33% |
| Mar 31, 2025 | 210.17% |
| Dec 31, 2024 | 521.88% |
| Sep 30, 2024 | 116.01% |